Citation Impact
Citing Papers
Forms of Intellectual and Ethical Development in the College Years: A Scheme. Jossey-Bass Higher and Adult Education Series.
1999 Standout
The dynamic course of psychological outcomes following the Victorian Black Saturday bushfires
2020
Depression
2018 Standout
Children of Katrina: Lessons Learned About Postdisaster Symptoms and Recovery Patterns
2010
Growing up in the shadow of Chornobyl: adolescents’ risk perceptions and mental health
2010
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Artificial Intelligence for Mental Health and Mental Illnesses: an Overview
2019
Epidemiology of child traumatic stress
2009
Child and adolescent mental health worldwide: evidence for action
2011 Standout
Disasters and youth: A meta-analytic examination of posttraumatic stress.
2010
Effectiveness of a School-Based Group Psychotherapy Program for War-Exposed Adolescents: A Randomized Controlled Trial
2008
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Candidate-Gene Approach in Posttraumatic Stress Disorder After Urban Violence: Association Analysis of the Genes Encoding Serotonin Transporter, Dopamine Transporter, and BDNF
2011
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Psychedelics
2016 Standout
Risk and resilience in family well-being during the COVID-19 pandemic.
2020 Standout
A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
2012
Symptoms and coping in Sri Lanka 20–21 months after the 2004 tsunami
2008
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
2014 Standout
Five Essential Elements of Immediate and Mid–Term Mass Trauma Intervention: Empirical Evidence
2007
Artificial intelligence in drug development: present status and future prospects
2018 Standout
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
2015
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Alzheimer's disease: clinical trials and drug development
2010
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
2023 Standout
Mental health and quality of life survey among child survivors of the 2008 Sichuan earthquake
2010
Disease-modifying drugs in Alzheimer's disease
2013
Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades
2012
Molecular biomarkers of depression
2016
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Comparison of the Chernobyl and Fukushima nuclear accidents: A review of the environmental impacts
2013 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Development of allosteric modulators of GPCRs for treatment of CNS disorders
2013
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Artificial intelligence in drug discovery and development
2020 Standout
Climate change concerns impact on young Australians’ psychological distress and outlook for the future
2023 StandoutNobel
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
2012
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Education in Emergencies: A Review of Theory and Research
2016 Standout
Organizational Response to Adversity: Fusing Crisis Management and Resilience Research Streams
2017 Standout
Translational Findings on Brain-Derived Neurotrophic Factor and Anxiety: Contributions from Basic Research to Clinical Practice
2013 Standout
Cigarette Smoking by Patients With Serious Mental Illness, 1999–2016: An Increasing Disparity
2017
Schizophrenia: a review.
2007
Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
2012 Standout
Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability
2012
Resilience definitions, theory, and challenges: interdisciplinary perspectives
2014 Standout
Religion, Spirituality, and Health: The Research and Clinical Implications
2012 Standout
Weighing the Costs of Disaster
2010
Works of David P. Walling being referenced
Paliperidone Extended-Release in Schizoaffective Disorder
2010
Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia
2011
Cognitive Functioning Predicts Outpatient Service Utilization in Schizophrenia
2004
PTSD and dopaminergic genes, DRD2 and DAT, in multigenerational families exposed to the Spitak earthquake
2010
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
2015
Depression and PTSD symptoms among bereaved adolescents 6½ years after the 1988 spitak earthquake
2008
A Prospective Study of Posttraumatic Stress and Depressive Reactions Among Treated and Untreated Adolescents 5 Years After a Catastrophic Disaster
2005
Association of TPH1, TPH2, and 5HTTLPR with PTSD and depressive symptoms
2012
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
2017
Longitudinal study of PTSD, depression, and quality of life among adolescents after the Parnitha earthquake
2011
A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
2013
Poster #220 A PHASE 1B STUDY INVESTIGATING THE POTENTIAL INTERACTION BETWEEN LY2140023 AND SECOND GENERATIONANTIPSYCHOTICS IN SUBJECTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER
2012
P2‐377: A phase 2, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL‐108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment
2008